paper
design
synthesi
scaffold
compris
primaquin
pq
motif
cinnam
acid
deriv
cad
bound
directli
compound
via
spacer
compound
report
first
seri
compound
pq
variou
cad
connect
amid
bond
second
seri
acylsemicarbazid
function
group
built
pq
amino
group
conhnh
spacer
carbonyl
group
origin
cad
pqcad
amid
prepar
simpl
onestep
condens
reaction
pq
seri
cad
chlorid
method
benzotriazolid
method
b
synthesi
acylsemicarbazid
includ
activ
pq
benzotriazol
prepar
pqsemicarbazid
condens
cad
chlorid
synthes
pqcad
conjug
evalu
anticanc
antivir
antioxid
activ
almost
compound
seri
select
toward
cell
line
activ
micromolar
concentr
ofluoro
deriv
show
high
activ
hela
particular
sw
cell
line
acylsemicarbazid
benzodioxol
ring
especi
methoxi
chloroor
trifluoromethylsubstitu
para
posit
show
high
select
high
inhibitori
activ
cell
line
micromolar
nanomolar
level
acylsemicarbazid
deriv
trifluoromethyl
group
show
specif
activ
human
coronaviru
concentr
alter
normal
cell
morpholog
compound
exert
potent
reduc
activ
dpph
test
togeth
methoxi
compound
benzodioxol
pcl
mcf
acylsemicarbazid
amid
present
highest
lp
inhibit
dimethoxi
deriv
potent
lox
inhibitor
ic
perform
biolog
test
gave
evid
acylsemicarbazid
function
group
superior
bind
group
pqcad
conjug
molecular
hybrid
approach
base
combin
pharmacophor
moieti
differ
compound
use
produc
new
hybrid
molecul
cinnam
acid
deriv
cad
primaquin
pq
motif
cinnam
acid
ca
acid
acid
deriv
natur
occur
substanc
found
variou
plant
import
intermedi
biosynthet
pathway
secondari
metabolit
play
key
role
plant
growth
develop
reproduct
diseas
resist
numer
research
paper
report
variou
pharmacolog
activ
cad
first
exhibit
strong
antimicrobi
antifung
antivir
activ
review
natur
synthet
cad
antimicrobi
activ
recent
publish
cad
show
good
moder
antitubercular
activ
synergist
activ
antitubercular
drug
mani
cad
especi
phenol
hydroxyl
group
wellknown
antioxid
suppos
sever
health
benefit
due
strong
free
radic
scaveng
properti
methoxi
substitut
cinnam
play
import
role
control
inflammatori
diseas
methoxi
substitut
octylcinnam
effici
sunscreen
agent
cad
possess
hepatoprotect
hypolipidem
activ
halogen
deriv
cn
depress
activ
amid
deriv
ca
potenti
antimalari
lead
ncinnamoyl
chloroquin
pq
aminoacridin
deriv
report
dualact
antimalari
antiprolif
agent
anticanc
potenti
piplartin
ca
alkaloidimid
deriv
pepper
variou
cad
report
numer
paper
review
bezerra
de
cowork
final
ca
motif
present
sever
approv
antiallerg
drug
cinnarizin
cinaserin
tranilast
antiplatelet
agent
ozagrel
hand
pq
wellknown
antimalari
drug
pronounc
antiprolif
activ
numer
report
corrobor
anticanc
properti
antimalari
drug
class
use
adjuv
chemotherapi
sever
antimalari
reach
clinic
stage
anticanc
research
sever
paper
shown
pq
deriv
urea
acylsemicarbazid
type
possess
strong
antiprolif
effect
number
tumor
cell
line
andor
high
select
toward
breast
cell
line
activ
compound
one
aromat
ring
attach
pq
scaffold
via
nitrogenand
oxygenrich
spacer
urea
carbam
hydroxyurea
doubl
urea
literatur
survey
show
hydroxysemicarbazid
potenti
antitumor
agent
well
light
consider
design
seri
hybrid
molecul
cinnamoyl
residu
aromat
compon
bound
amid
acylsemicarbazid
function
pq
pharmacophor
new
seri
pq
deriv
differ
previou
one
aromat
region
type
spacer
present
studi
report
synthesi
character
pqcad
conjug
evalu
potenti
anticanc
antivir
agent
chemoprevent
potenti
carcinogenesi
inhibit
lipoxygenas
marker
antiinflammatori
activ
antioxid
abil
pqcad
evalu
well
two
seri
pqcad
conjug
prepar
ca
acid
methoxi
dimethoxi
trimethoxi
methylenedioxi
chloro
fluoro
trifluoromethyl
bistrifluoromethylcinnam
acid
cad
compon
seri
pq
ca
q
moieti
directli
bound
amid
bond
seri
connect
conhnh
spacer
termin
amino
group
pq
hydrazid
spacer
ca
carbonyl
group
togeth
form
new
acylsemicarbazid
function
group
synthet
rout
lead
pqcad
conjug
outlin
scheme
two
method
prepar
amid
appli
acid
chlorid
method
benzotriazolid
method
b
use
activ
cad
intermedi
method
gave
product
similar
yield
cadbenzotriazolid
prepar
follow
procedur
describ
previous
benzotriazolid
variou
carboxyl
acid
synthes
transform
ester
amid
hydroxam
acid
benzotriazolid
activ
amid
pqbenzotriazolid
activ
urea
prepar
start
compound
btccl
cad
pq
presenc
triethylamin
tea
reaction
hydrazin
gave
semicarbazid
react
chlorid
afford
pqcad
conjug
gener
formula
compound
stabl
intermedi
appli
previou
work
synthes
numer
pq
deriv
new
compound
fulli
character
usual
spectroscop
method
ir
h
cnmr
ms
element
analys
spectral
data
consist
propos
structur
summar
experiment
section
detail
supplementari
materi
synthes
compound
report
previous
without
spectral
analyt
data
compound
use
reaction
step
without
purif
structur
confirm
indirectli
presenc
pq
residu
compound
confirm
nmr
spectra
hydrogen
atom
next
pyridin
nitrogen
occur
hnmr
spectra
methoxi
group
ch
chiral
carbon
multiplet
methyl
group
ppm
c
spectra
correspond
carbon
atom
appear
ppm
respect
cad
benzen
ring
afford
addit
hydrogen
carbon
signal
aromat
region
signal
methoxi
group
product
locat
close
pq
methoxi
group
group
present
adjac
aromat
carbon
atom
split
cnmr
spectra
appear
quartet
ppm
respect
amid
nh
signal
seri
visibl
hnmr
spectra
amin
nh
ppm
exchang
compound
seri
show
four
nh
signal
nh
close
cad
carbonyl
appear
singlet
ppm
next
nh
singlet
pq
termin
amino
group
pq
nh
group
next
two
method
prepar
amid
appli
acid
chlorid
method
benzotriazolid
method
b
use
activ
cad
intermedi
method
gave
product
similar
yield
cadbenzotriazolid
prepar
follow
procedur
describ
previous
benzotriazolid
variou
carboxyl
acid
synthes
transform
ester
amid
hydroxam
acid
benzotriazolid
activ
amid
pqbenzotriazolid
activ
urea
prepar
start
compound
btccl
cad
pq
presenc
triethylamin
tea
reaction
hydrazin
gave
semicarbazid
react
chlorid
afford
pqcad
conjug
gener
formula
compound
stabl
intermedi
appli
previou
work
synthes
numer
pq
deriv
new
compound
fulli
character
usual
spectroscop
method
ir
h
cnmr
ms
element
analys
spectral
data
consist
propos
structur
summar
experiment
section
detail
supplementari
materi
synthes
compound
report
previous
without
spectral
analyt
data
compound
use
reaction
step
without
purif
structur
confirm
indirectli
presenc
pq
residu
compound
confirm
nmr
spectra
hydrogen
atom
next
pyridin
nitrogen
occur
hnmr
spectra
methoxi
group
ch
chiral
carbon
multiplet
methyl
group
ppm
c
spectra
correspond
carbon
atom
appear
ppm
respect
cad
benzen
ring
afford
addit
hydrogen
carbon
signal
aromat
region
signal
methoxi
group
product
locat
close
pq
methoxi
group
cf
group
present
adjac
aromat
carbon
atom
split
cnmr
spectra
appear
quartet
ppm
respect
amid
nh
signal
seri
visibl
hnmr
spectra
amin
nh
ppm
exchang
compound
seri
show
four
nh
signal
nh
close
cad
carbonyl
appear
singlet
ppm
next
nh
singlet
pq
termin
amino
group
pq
nh
group
next
chiral
atom
doublet
ppm
presenc
one
compound
two
carbonyl
group
compound
indic
appear
strong
stretch
vibrat
band
correspond
ir
spectra
cm
signal
ppm
cnmr
spectra
pqcad
amid
almost
acylsemicarbazid
fulli
agreement
lipinski
rule
five
gelovani
rule
prospect
small
molecular
drug
mw
log
p
number
hbond
donor
number
hbond
acceptor
molecular
polar
surfac
area
psa
molar
refract
mr
within
rang
cm
mol
number
atom
paramet
calcul
chemicalizeorg
program
present
tabl
consid
individu
biolog
medicin
import
pq
cad
want
explor
novel
chemic
entiti
base
pq
cad
moieti
respect
biolog
signific
synthes
pqcad
conjug
evalu
anticanc
antivir
antiinflammatori
antioxid
activ
result
summar
tabl
sorsorafenib
ciscisplatin
ic
concentr
caus
growth
inhibit
b
colon
carcinoma
hct
c
lung
adenocarcinoma
newli
prepar
pqcad
deriv
design
prepar
primarili
potenti
anticanc
agent
antiprolif
activ
evalu
vitro
five
differ
type
human
tumor
cell
line
lymphoblast
leukemia
cem
cervic
carcinoma
hela
lung
carcinoma
colon
carcinoma
sw
breast
carcinoma
murin
lymphocyt
leukemia
compar
standard
anticanc
drug
sorafenib
cisplatin
pq
amid
deriv
show
weak
activ
cem
activ
cell
line
compound
seri
inact
sw
howev
show
mild
strong
activ
ic
cell
line
activ
hela
vari
much
deriv
show
strong
activ
low
micromolar
concentr
ic
respect
amid
deriv
either
inact
activ
weak
rest
compound
seri
tabl
suscept
tumor
cell
line
practic
compound
activ
low
micromolar
concentr
activ
ofluoro
deriv
ic
acylsemicarbazid
deriv
activ
amid
deriv
less
activ
test
cell
line
gener
activ
four
compound
show
strong
activ
variabl
activ
test
cell
line
interest
note
three
activ
pqcad
deriv
bear
substitu
para
posit
methoxi
chloro
trifluoromethyl
respect
activ
compound
trifluoromethyl
deriv
ic
nanomolar
scale
nm
deriv
exert
higher
activ
anticanc
refer
drug
higher
activ
pq
interest
find
current
research
high
sensit
tumor
cell
seri
compound
alreadi
notic
discuss
phenomenon
previou
work
pq
deriv
investig
underli
mechan
progress
compound
evalu
broad
varieti
virus
includ
herp
simplex
viru
type
ko
herp
simplex
viru
g
herp
simplex
viru
tk
ko
acv
r
vaccinia
viru
adeno
viru
human
coronaviru
hel
cell
cultur
activ
compar
refer
compound
brivudin
cidofovir
acyclovir
gancyclovir
zalcitabin
alovudin
urtica
dioica
agglutinin
uda
ribavirin
respect
compound
seri
inact
toward
test
virus
acylsemicarbazid
deriv
ec
respect
ec
show
moder
activ
human
coronaviru
three
two
fold
lower
activ
uda
ec
compound
alter
normal
cell
morpholog
confluent
hel
cell
cultur
concentr
data
shown
select
ratio
si
mcc
ec
ratio
eg
ratio
minimum
cytotox
concentr
concentr
caus
microscop
detect
alter
normal
cell
morpholog
concentr
requir
reduc
virusinduc
cytopathogen
close
ten
worth
mention
three
activ
compound
contain
trifluoromethyl
group
mcf
ec
pcf
ec
two
mcf
ec
halogen
methoxi
deriv
inact
therefor
one
conclud
acylsemicarbazid
function
group
presenc
cf
motif
may
respons
enhanc
antivir
activ
human
coronaviru
find
could
use
structur
optim
cytotox
measur
base
inhibit
hel
growth
result
express
mcc
mcc
valu
pqcad
deriv
equal
higher
except
around
antioxid
potenti
new
pq
cad
hybrid
studi
compar
wellknown
antioxid
agent
nordihydroguaiaret
acid
ndga
acid
trolox
two
differ
antioxid
assay
use
interact
stabl
dpph
free
radic
ii
interact
watersolubl
azo
compound
dihydrochlorid
aaph
use
sourc
peroxyl
radic
dpph
interact
test
compound
examin
concentr
min
dpphreduc
abil
ra
amid
deriv
low
miss
howev
increas
observ
increas
concentr
highest
activ
present
unsubstitut
deriv
tabl
contrari
acylsemicarbazid
deriv
exhibit
stronger
antioxid
activ
concentr
abil
found
concentr
time
depend
major
compound
trifluoromethyl
deriv
dimethoxi
chloro
deriv
show
highest
reduc
activ
within
dataset
perus
ra
valu
etc
support
fact
keep
rest
structur
characterist
presenc
acylsemicarbazid
function
group
correl
higher
antioxid
activ
acylsemicarbazid
seri
attach
cf
group
cinnam
ring
enhanc
antioxid
abil
presenc
two
vicin
methoxi
group
p
lead
higher
activ
compar
presenc
singl
methoxi
group
contrari
third
methoxi
group
diminish
activ
probabl
due
steric
reason
bulki
radic
dpph
could
approach
interact
replac
phenyl
ring
benzo
dioxol
increas
activ
natur
andor
posit
halogen
atom
cinnam
ring
affect
antioxid
potenc
thu
pcl
deriv
found
potent
group
compound
correl
overal
lipophil
activ
found
tabl
howev
hydrophil
contribut
spacer
seem
play
signific
role
log
p
etc
studi
aaph
use
free
radic
initi
follow
oxid
chang
linol
acid
conjug
dien
hydroperoxid
result
show
amid
deriv
significantli
inhibit
lipid
peroxid
lp
compound
benzodioxol
ring
exhibit
highest
activ
acylsemicarbazid
gener
present
higher
lp
inhibit
amid
unsubstitut
methoxi
benzodioxol
pcl
mcf
deriv
potent
correl
lipophil
lp
inhibit
found
lox
inhibitor
attract
attent
initi
potenti
agent
treatment
inflammatori
allerg
diseas
certain
type
cancer
cardiovascular
diseas
order
diminish
procancer
mechan
key
treatment
strategi
reduc
free
radic
load
antioxid
activ
scaveng
reactiv
oxygen
speci
import
prevent
potenti
damag
cellular
compound
dna
protein
lipid
moreov
found
lox
inhibitor
may
chemoprevent
activ
lung
carcinogenesi
report
publish
past
three
decad
support
growthregulatori
role
arachidon
acid
metabolit
etiolog
mammari
carcinogenesi
studi
demonstr
level
sever
eicosanoid
increas
breast
cancer
comparison
benign
breast
tumour
context
evalu
newli
prepar
pqcad
conjug
abil
inhibit
soybean
lipoxygenas
lox
test
compound
amid
except
inact
howev
acylsemicarbazid
exhibit
signific
activ
lox
inhibit
assay
ic
valu
dimethoxi
deriv
potent
inhibitor
ic
valu
doubl
concentr
refer
compound
ndga
follow
compound
high
log
p
valu
activ
idea
lipophil
import
physicochem
properti
lox
inhibit
support
result
indic
lox
inhibit
accompani
correl
antilipid
peroxid
dpph
radic
scaveng
activ
gener
presenc
acylsemicarbazid
moieti
pqcad
conjug
led
hybrid
better
biolog
respons
melt
point
measur
stuart
melt
point
apparatu
barloworld
scientif
staffordshir
uk
open
capillari
uncorrect
valu
ir
spectra
record
ftir
perkin
elmer
paragon
uvvi
spectra
lambda
doubl
beam
spectrophotomet
perkinelm
waltham
usa
nmr
h
c
spectra
record
c
nmr
avanc
bruker
rheinstetten
germani
varian
inova
spectromet
varian
paloalto
ca
usa
mhz
h
mhz
c
nuclei
respect
chemic
shift
report
part
per
million
ppm
use
tetramethylsilan
refer
h
dmso
residu
peak
refer
ca
acid
acryl
acid
acid
pcoumar
acid
methyl
ether
acid
caffeic
acid
dimethyl
ether
acid
methylenedioxi
cinnam
acid
acid
acid
acid
trifluoromethyl
cinnam
acid
trifluoromethyl
cinnam
acid
trifluoromethyl
cinnam
acid
purchas
sigmaaldrich
st
loui
mo
usa
predominantli
tran
stereoisom
triazol
bth
triphosgen
pq
diphosph
tea
hydrazin
hydrat
lox
linol
acid
sodium
salt
dpph
ndga
aaph
trolox
purchas
sigmaaldrich
well
pq
prepar
pq
diphosph
prior
use
reaction
pq
run
light
protect
solut
ca
cad
equiv
tea
equiv
dri
toluen
solut
btccl
equiv
dri
toluen
ad
dropwis
reaction
mixtur
stir
room
temperatur
min
solvent
evapor
residu
dissolv
etoach
mixtur
organ
layer
extract
water
dri
anhydr
sodium
sulfat
filter
evapor
compound
synthes
accord
gener
procedur
use
acid
g
mmol
btccl
g
mmol
crude
product
g
tritur
ether
use
reaction
without
purif
compound
synthes
accord
gener
procedur
use
acid
g
mmol
btccl
g
mmol
crude
product
g
tritur
etherpetroleth
use
reaction
without
purif
compound
synthes
accord
gener
procedur
use
acid
g
mmol
btccl
g
mmol
crude
product
g
tritur
ether
use
reaction
without
purif
solut
ca
cad
equiv
thionyl
chlorid
equiv
two
drop
dmf
dri
toluen
stir
room
temperatur
h
solvent
evapor
residu
dissolv
dri
toluen
evapor
use
reaction
without
purif
method
suspens
pq
diphosph
equiv
tea
equiv
dri
dichloromethan
stir
room
temperatur
min
solut
chlorid
equiv
dri
dichloromethan
ad
dropwis
reaction
mixtur
stir
room
temperatur
light
protect
h
solvent
remov
reduc
pressur
residu
dissolv
ethyl
naoh
mixtur
organ
layer
extract
naoh
solut
water
dri
anhydr
sodium
sulfat
filter
evapor
crude
product
purifi
column
chromatographi
method
b
naoh
solut
ad
solut
pq
diphosph
equiv
water
ph
reach
pq
base
extract
dichloromethan
organ
layer
dri
anhydr
sodium
sulfat
filter
evapor
pq
tea
equiv
dissolv
dri
dioxan
ad
dropwis
solut
equiv
dri
dioxan
reaction
mixtur
stir
room
temperatur
overnight
evapor
reduc
pressur
residu
dissolv
ethyl
acet
extract
naoh
solut
water
dri
anhydr
sodium
sulfat
filter
evapor
crude
product
purifi
column
chromatographi
e
n
pentyl
compound
synthes
accord
gener
procedur
method
use
chlorid
g
mmol
pq
diphosph
g
mmol
purif
column
chromatographi
ch
cl
meoh
recrystal
etoaceth
pure
compound
obtain
g
mp
c
ir
kbr
cm
e
n
pentyl
acrylamid
compound
synthes
accord
gener
procedur
use
chlorid
g
mmol
pq
diphosph
g
mmol
method
compound
g
mmol
pq
diphosph
g
mmol
method
b
purif
column
chromatographi
petroleum
etheretoac
pure
compound
obtain
g
method
g
method
b
mp
c
ir
kbr
cm
j
e
n
pentyl
acrylamid
compound
synthes
accord
gener
procedur
use
chlorid
g
mmol
pq
diphosph
g
mmol
method
compound
g
mmol
pq
diphosph
g
mmol
method
b
purif
column
chromatographi
petroleum
etheretoacmeoh
crystal
etoac
pure
compound
obtain
g
method
g
method
b
mp
c
ir
kbr
cm
n
pentyl
acrylamid
compound
synthes
accord
gener
procedur
method
use
chlorid
g
mmol
pq
diphosph
g
mmol
purif
column
chromatographi
ch
cl
meoh
recrystal
etoaceth
pure
compound
obtain
g
mp
c
ir
kbr
cm
compound
prepar
accord
procedur
publish
earlier
synthesi
n
amino
pentyl
hydrazinecarboxamid
titl
compound
prepar
follow
previous
publish
procedur
solut
chlorid
equiv
dri
dichloromethan
solut
semicarbazid
equiv
tea
equiv
dri
dichloromethan
ad
dropwis
reaction
mixtur
stir
overnight
room
temperatur
light
protect
solvent
remov
reduc
pressur
residu
dissolv
ethyl
naoh
mixtur
organ
layer
extract
naoh
solut
water
dri
anhydr
sodium
sulfat
filter
evapor
crude
product
purifi
column
chromatographi
e
pentyl
semicarbazid
compound
synthes
accord
gener
procedur
use
chlorid
g
mmol
compound
g
mmol
purif
column
chromatographi
ch
cl
meoh
oili
product
obtain
crystal
long
storag
low
temperatur
g
mp
c
decomp
e
trifluoromethyl
phenyl
acryloyl
pentyl
semicarbazid
compound
synthes
accord
gener
procedur
use
chlorid
g
mmol
compound
g
mmol
purif
column
chromatographi
ch
cl
meoh
crystal
toluen
pure
compound
obtain
g
mp
c
decomp
ir
kbr
cm
experi
carri
murin
lymphocyt
leukemia
cell
line
five
human
tumor
cell
line
cem
hela
sw
cell
cultur
monolay
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
lglutamin
uml
penicillin
streptomycin
humidifi
atmospher
co
c
growth
inhibit
activ
compound
assess
describ
previous
cell
line
inocul
onto
seri
standard
microtit
plate
day
cellsml
sw
cellsml
cem
depend
growth
tumor
cell
line
test
agent
ad
tenfold
dilut
cell
cultur
incub
day
co
c
work
dilut
compound
freshli
prepar
day
test
sw
day
cem
cell
growth
rate
evalu
first
light
microscop
viabl
cell
count
andor
perform
mtt
assay
detect
dehydrogenas
activ
live
dead
cell
absorb
measur
micropl
reader
nm
absorb
directli
proport
number
live
metabol
activ
cell
result
express
ic
concentr
necessari
inhibit
ic
valu
compound
calcul
concentrationrespons
curv
use
linear
regress
analysi
fit
test
concentr
give
percentag
growth
pg
valu
refer
valu
ie
howev
test
concentr
produc
pg
exceed
respect
refer
level
effect
eg
pg
valu
highest
test
concentr
assign
default
valu
preced
sign
minimum
two
individu
experi
carri
test
point
perform
quadrupl
antivir
activ
herp
simplex
viru
type
ko
herp
simplex
viru
g
herp
simplex
viru
tk
ko
acv
r
vaccinia
viru
adeno
viru
human
coronaviru
determin
essenti
describ
previous
h
incub
period
residu
viru
remov
infect
cell
incub
medium
contain
differ
concentr
test
compound
incub
day
c
virusinduc
cytopathogen
monitor
microscop
antivir
activ
express
concentr
requir
reduc
virusinduc
cytopathogen
ec
cytotox
measur
base
inhibit
hel
cell
growth
cell
seed
cellswel
microtit
plate
medium
contain
differ
concentr
test
compound
ad
day
incub
c
alter
morpholog
cell
cultur
record
light
microscop
cytotox
express
mcc
solut
dpph
absolut
ethanol
appropri
volum
compound
final
concentr
dissolv
dmso
ad
absorb
record
nm
min
room
temperatur
experi
repeat
least
triplic
standard
deviat
absorb
less
mean
ndga
use
experiment
condit
refer
compound
initi
lipid
peroxid
free
radic
aaph
use
final
solut
uv
cuvett
consist
linol
sodium
solut
c
mm
ml
phosphat
buffer
c
ph
thermost
c
aaph
solut
c
mm
test
compound
ad
experi
perform
c
air
oxid
linol
acid
sodium
salt
monitor
nm
assay
repeat
least
triplic
standard
deviat
absorb
less
mean
trolox
use
experiment
condit
refer
compound
antiinflammatori
activ
lox
inhibit
studi
vitro
lox
inhibitori
assay
vitro
accomplish
describ
previous
test
compound
stock
solut
mm
dmso
incub
room
temperatur
sodium
linol
c
mm
ml
lox
enzym
solut
mv
salin
convers
sodium
linol
acid
measur
nm
compar
refer
inhibitor
sever
concentr
use
ic
determin
assay
repeat
least
triplic
standard
deviat
absorb
less
mean
ndga
use
experiment
condit
refer
compound
design
synthes
new
scaffold
compris
cad
pq
motif
bound
amid
compound
acylsemicarbazid
bond
compound
twenti
two
pqcad
conjug
prepar
subject
extens
biolog
evalu
anticanc
screen
vitro
six
select
cancer
cell
line
show
acylsemicarbazid
deriv
gener
activ
amid
deriv
almost
compound
seri
select
toward
cell
line
activ
micromolar
concentr
select
compound
amid
seri
ofluoro
deriv
show
high
activ
hela
particular
sw
cell
line
four
acylsemicarbazid
deriv
name
benzodioxol
ring
especi
methoxi
chloro
trifluoromethyl
substitu
para
posit
cinnam
benzen
ring
show
high
select
strong
activ
cell
line
micromolar
nanomolar
level
compound
might
provid
fertil
much
need
lead
anticanc
drug
discoveri
trifluoromethyl
acylsemicarbazid
deriv
show
select
antivir
activ
human
coronaviru
strain
concentr
alter
normal
cell
morpholog
could
therefor
consid
potenti
drug
lead
structur
optim
compound
togeth
exert
potent
antioxid
abil
interact
free
stabl
radic
dpph
unsubstitut
methoxi
benzodioxol
pcl
mcf
acylsemicarbazid
amid
present
highest
antilipid
peroxid
activ
dimethoxi
deriv
potent
lox
inhibitor
ic
result
support
princip
idea
pqcad
hybrid
lead
multifunct
agent
author
declar
conflict
interest
